1. Home
  2. ANNX vs TIGR Comparison

ANNX vs TIGR Comparison

Compare ANNX & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.17

Market Cap

873.3M

Sector

Health Care

ML Signal

HOLD

Logo UP Fintech Holding Ltd representing fifteen

TIGR

UP Fintech Holding Ltd representing fifteen

HOLD

Current Price

$4.97

Market Cap

856.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
TIGR
Founded
2011
2014
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
873.3M
856.0M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
ANNX
TIGR
Price
$5.17
$4.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$16.50
$14.20
AVG Volume (30 Days)
2.5M
2.0M
Earning Date
05-11-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.75
Revenue Next Year
$16,320.74
$5.95
P/E Ratio
N/A
$9.77
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$4.00
52 Week High
$7.18
$13.55

Technical Indicators

Market Signals
Indicator
ANNX
TIGR
Relative Strength Index (RSI) N/A 60.60
Support Level N/A $4.40
Resistance Level N/A $7.00
Average True Range (ATR) 0.00 0.15
MACD 0.00 0.03
Stochastic Oscillator 0.00 81.84

Price Performance

Historical Comparison
ANNX
TIGR

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About TIGR UP Fintech Holding Ltd representing fifteen

UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.

Share on Social Networks: